What is Dolutegravir?

Category: Prescription Drugs

Most popular types: Tivicay Tivicay HIV Post-Exposure Prophylaxis

false

See also: Abacavir-dolutegravir-lamivudine Triumeq

Dolutegravir is a drug used in combination with other anti-retroviral drugs to treat HIV (Human Immunodeficiency Virus). It is an integrase inhibitor, meaning that it interferes with the replication of the virus in the human body.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 8

Commonly reported side effects and conditions associated with Dolutegravir

Side effect Patients

Dosages

Based on patients currently taking Dolutegravir

Dosage Patients
50 mg daily 10
1 tablet(s) daily 1

Why patients stopped taking Dolutegravir

Multiple reasons could be selected

Reason Patients
Other 2
Course of treatment ended 1
See all 3 patients who've stopped taking Dolutegravir

Duration

Currently taking Dolutegravir

Duration Patients
6 months - 1 year 1
1 - 2 years 4
2 - 5 years 6

Stopped taking Dolutegravir

Duration Patients
Less than 1 month 1
6 months - 1 year 1
1 - 2 years 1
Adherence
Adherence Evaluations
Always 8
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 7
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 0
$25-49 1
< $25 1
Not specified 5

What people switch to and from

Patients started taking Dolutegravir after stopping:

Treatment Patients
Ritonavir (Norvir) 3
Darunavir (Prezista) 2
Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) 1
Efavirenz (Sustiva) 1
Emtricitabine-Tenofovir (Truvada) 1

Show all 8 treatments patients report switching from

Patients stopped taking Dolutegravir and switched to:

Treatment Patients
Triumeq 3
Last updated:
There are no evaluations for Dolutegravir.